Centamin Egypt Limited
17 December 2007
17 December 2007
Centamin Egypt Limited
('Centamin' or 'the Company')
Issue of Equity
Centamin Egypt Limited (TSX:CEE, ASX:CNT, AIM:CEY) announces that, following the
exercise of unquoted broker warrants, 751,431 ordinary shares have been issued
and allotted at an exercise price of C$0.8600 per share. A further 100,000
ordinary shares have been issued and allotted following the exercise of unquoted
employee options at an exercise price of A$0.7106 per share.
Application has been made for the new ordinary shares to be admitted to trading
on AIM. The new ordinary shares will rank pari passu with the existing ordinary
shares in the Company and trading of these shares on AIM is expected to commence
on 21 December 2007.
The total number of Ordinary Shares on issue following this issue is
762,123,163.
For more information please contact:
Centamin Egypt Limited
+ 61 (8) 9316 2640
Josef El-Raghy
www.centamin.com
Pelham Public Relations
+ 44 (0) 207 743 6376
Candice Sgroi
Mobile: + 44 (0) 7894 462 114
Ambrian Partners Limited
+ 44 (0)207 776 6400
Richard Brown
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.